• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CpG ODN7909对喉表皮样癌Hep-2细胞系的放射增敏作用。

Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line.

作者信息

Wang Shu, Liu Xiaoqun, Qiao Tiankui, Zhang Qi

机构信息

Department of Oncology, Jinshan Hospital, Medical Centre of Fudan University, Jinshan District, Shanghai, China.

出版信息

J Int Med Res. 2017 Dec;45(6):2009-2022. doi: 10.1177/0300060517728634. Epub 2017 Sep 18.

DOI:10.1177/0300060517728634
PMID:29239279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5805225/
Abstract

Objective To evaluate the radiosensitivity effect of CpG oligodeoxyribonucleotide (ODN) 7909 on human epidermoid cancer strain-2 (Hep-2) cells in vitro and discuss the potential for improved radiotherapy treatment in patients with laryngeal squamous cell carcinoma. Methods Toll-like receptor ( TLR) 9 expression was assessed in Hep-2 cells using Western blots and reverse transcription polymerase chain reaction. Cell Counting Kit-8 was used to detect Hep-2 cell viability at 24 and 48 h following treatment with different CpG ODN7909 concentrations. Cellular colonization was evaluated using microscopy. Cell cycle distribution and apoptosis rate was determined with flow cytometry. Interleukin (IL)-12 and tumour necrosis factor (TNF)-α concentrations were detected by enzyme-linked immunosorbent assay. Results Hep-2 cells were found to express TLR9, and CpG ODN7909 treatment suppressed Hep-2 cell viability in a dose- and time-dependent manner. Cell survival curve analyses revealed a sensitivity enhancement ratio of the mean death dose of 1.225 for CpG ODN7909 plus irradiation versus irradiation alone. Furthermore, the population of Gap 2/mitotic-phase cells, apoptosis rate and secreted IL-12 and TNF-α levels were significantly increased in Hep-2 cells treated with CpG ODN7909 plus irradiation versus IR alone. Conclusion CpG ODN7909 enhanced the radiosensitivity of Hep-2 cells in vitro.

摘要

目的 评估CpG寡脱氧核苷酸(ODN)7909对人表皮样癌2株(Hep-2)细胞的体外放射增敏作用,并探讨其改善喉鳞状细胞癌患者放射治疗效果的潜力。方法 采用蛋白质免疫印迹法和逆转录聚合酶链反应评估Hep-2细胞中Toll样受体(TLR)9的表达。使用细胞计数试剂盒-8检测不同浓度CpG ODN7909处理24和48小时后Hep-2细胞的活力。通过显微镜评估细胞集落形成情况。用流式细胞术测定细胞周期分布和凋亡率。采用酶联免疫吸附测定法检测白细胞介素(IL)-12和肿瘤坏死因子(TNF)-α的浓度。结果 发现Hep-2细胞表达TLR9,且CpG ODN7909处理以剂量和时间依赖性方式抑制Hep-2细胞活力。细胞存活曲线分析显示,与单纯照射相比,CpG ODN7909联合照射的平均死亡剂量的增敏比为1.225。此外,与单纯照射相比,CpG ODN7909联合照射处理的Hep-2细胞中G2/有丝分裂期细胞比例、凋亡率以及分泌的IL-12和TNF-α水平均显著增加。结论 CpG ODN7909在体外增强了Hep-2细胞的放射敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/16592528852a/10.1177_0300060517728634-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/7c8a501c27b2/10.1177_0300060517728634-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/210c332c5566/10.1177_0300060517728634-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/c171064e011a/10.1177_0300060517728634-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/ae7e61fe2a68/10.1177_0300060517728634-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/ddf5091a65d6/10.1177_0300060517728634-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/16592528852a/10.1177_0300060517728634-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/7c8a501c27b2/10.1177_0300060517728634-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/210c332c5566/10.1177_0300060517728634-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/c171064e011a/10.1177_0300060517728634-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/ae7e61fe2a68/10.1177_0300060517728634-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/ddf5091a65d6/10.1177_0300060517728634-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f4/5805225/16592528852a/10.1177_0300060517728634-fig6.jpg

相似文献

1
Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line.CpG ODN7909对喉表皮样癌Hep-2细胞系的放射增敏作用。
J Int Med Res. 2017 Dec;45(6):2009-2022. doi: 10.1177/0300060517728634. Epub 2017 Sep 18.
2
Enhancement of radiosensitivity by CpG-oligodeoxyribonucleotide-7909 in human non-small cell lung cancer A549 cells.CpG-寡脱氧核苷酸-7909 增强人非小细胞肺癌 A549 细胞的放射敏感性。
Cancer Biother Radiopharm. 2010 Apr;25(2):165-70. doi: 10.1089/cbr.2009.0686.
3
CpG-ODN 7909 increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of Toll-like receptor 9.CpG-ODN 7909 通过过表达 Toll 样受体 9 增加辐射抗性人肺腺癌细胞系的辐射敏感性。
Cancer Biother Radiopharm. 2013 Sep;28(7):559-64. doi: 10.1089/cbr.2012.1450. Epub 2013 May 24.
4
[Effect of c-Met inhibitor AMG-102 on radiosensitivity in laryngeal squamous carcinoma cells].[c-Met抑制剂AMG-102对喉鳞状癌细胞放射敏感性的影响]
Zhonghua Zhong Liu Za Zhi. 2019 Dec 23;41(12):909-917. doi: 10.3760/cma.j.issn.0253-3766.2019.12.006.
5
CpG oligodeoxynucleotide induces apoptosis and cell cycle arrest in A20 lymphoma cells via TLR9-mediated pathways.CpG 寡脱氧核苷酸通过 TLR9 介导的途径诱导 A20 淋巴瘤细胞凋亡和细胞周期停滞。
Mol Immunol. 2013 Jul;54(3-4):327-37. doi: 10.1016/j.molimm.2013.01.001. Epub 2013 Jan 26.
6
Curcumin enhances the response of non-Hodgkin's lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2/M phase and inhibition of mTOR phosphorylation.姜黄素通过进一步诱导 G2/M 期细胞周期阻滞和抑制 mTOR 磷酸化,增强非霍奇金淋巴瘤细胞对电离辐射的反应。
Oncol Rep. 2013 Jan;29(1):380-6. doi: 10.3892/or.2012.2091. Epub 2012 Oct 19.
7
STAT3 blockade with shRNA enhances radiosensitivity in Hep-2 human laryngeal squamous carcinoma cells.短发夹 RNA 阻断 STAT3 增强 Hep-2 人喉鳞癌细胞的放射敏感性。
Oncol Rep. 2010 Feb;23(2):345-53.
8
Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line.通过RNA干扰抑制XIAP表达以抑制喉癌细胞系的增殖并增强其放射敏感性。
Auris Nasus Larynx. 2009 Jun;36(3):332-9. doi: 10.1016/j.anl.2008.08.006. Epub 2008 Nov 13.
9
CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production.CpG ODN107通过Toll样受体9(TLR9)介导的核因子κB(NF-κB)激活和一氧化氮(NO)生成增强人胶质瘤细胞的放射敏感性。
Tumour Biol. 2012 Oct;33(5):1607-18. doi: 10.1007/s13277-012-0416-1. Epub 2012 Jun 28.
10
Protective effect of CpG-oligodeoxynucleotides against low- and high-LET irradiation.CpG 寡脱氧核苷酸对低传能线密度和高传能线密度辐射的防护作用。
Cell Physiol Biochem. 2014;34(5):1663-74. doi: 10.1159/000366368. Epub 2014 Nov 5.

引用本文的文献

1
CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials.用于抗癌单一疗法的CpG寡脱氧核苷酸:从临床前阶段到临床试验
Pharmaceutics. 2021 Dec 28;14(1):73. doi: 10.3390/pharmaceutics14010073.
2
IL-17 Affects the Progression, Metastasis, and Recurrence of Laryngeal Cancer the Inhibition of Apoptosis through Activation of the PI3K/AKT/FAS/FASL Pathways.IL-17 通过激活 PI3K/AKT/FAS/FASL 通路影响喉癌的进展、转移和复发,抑制细胞凋亡。
J Immunol Res. 2020 Dec 18;2020:2953191. doi: 10.1155/2020/2953191. eCollection 2020.
3
Tanshinone sensitized the antitumor effects of irradiation on laryngeal cancer via JNK pathway.

本文引用的文献

1
CpG-induced antitumor immunity requires IL-12 in expansion of effector cells and down-regulation of PD-1.CpG诱导的抗肿瘤免疫在效应细胞扩增和程序性死亡受体1(PD-1)下调过程中需要白细胞介素-12(IL-12)。
Oncotarget. 2016 Oct 25;7(43):70223-70231. doi: 10.18632/oncotarget.11833.
2
Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.II期器官保留试验:多西他赛、顺铂和5-氟尿嘧啶诱导化疗有效后,晚期喉癌同步顺铂和放疗。
Head Neck. 2017 Feb;39(2):227-233. doi: 10.1002/hed.24571. Epub 2016 Aug 24.
3
丹参酮通过 JNK 通路增强放疗对喉癌的抗肿瘤作用。
Cancer Med. 2018 Oct;7(10):5187-5193. doi: 10.1002/cam4.1781. Epub 2018 Sep 21.
4
Toll-like receptor 9 activation by CpG oligodeoxynucleotide 7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway.CpG寡脱氧核苷酸7909激活Toll样受体9通过p53信号通路增强A549肺癌细胞的放射敏感性。
Oncol Lett. 2018 Apr;15(4):5271-5279. doi: 10.3892/ol.2018.7916. Epub 2018 Jan 31.
Effects of LG268 on Cell Proliferation and Apoptosis of NB4 Cells.
LG268对NB4细胞增殖和凋亡的影响。
Int J Med Sci. 2016 Jun 29;13(7):517-23. doi: 10.7150/ijms.15507. eCollection 2016.
4
Retrospective analysis of therapeutic effect and prognostic factors on early glottic carcinoma.早期声门癌治疗效果及预后因素的回顾性分析
Photodiagnosis Photodyn Ther. 2016 Sep;15:167-71. doi: 10.1016/j.pdpdt.2016.06.008. Epub 2016 Jul 1.
5
Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes.晚期喉癌的器官保存:问题与结果
J Clin Oncol. 2015 Oct 10;33(29):3262-8. doi: 10.1200/JCO.2015.61.2978. Epub 2015 Sep 8.
6
Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.T4a期喉癌的全喉切除术与喉保留术:治疗模式与生存结果
Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):594-601. doi: 10.1016/j.ijrobp.2015.03.004.
7
Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis.T1期声门癌放射治疗与激光显微手术的语音疗效:系统评价与Meta分析
Otolaryngol Head Neck Surg. 2015 May;152(5):811-9. doi: 10.1177/0194599815577103. Epub 2015 Apr 2.
8
Cancer survival in China, 2003-2005: a population-based study.2003 - 2005年中国癌症生存率:一项基于人群的研究。
Int J Cancer. 2015 Apr 15;136(8):1921-30. doi: 10.1002/ijc.29227. Epub 2014 Oct 3.
9
Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma.晚期喉癌和下咽鳞状细胞癌中,一线及辅助放化疗适应证转移的影响
Eur Arch Otorhinolaryngol. 2015 Aug;272(8):2017-25. doi: 10.1007/s00405-014-3134-z. Epub 2014 Jun 25.
10
The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma.经CpG-ODN处理的癌细胞分泌的IL-6在口腔鳞状细胞癌中部分通过TLR-9/AP-1途径促进T细胞免疫反应。
Int J Oncol. 2014 Jun;44(6):2103-10. doi: 10.3892/ijo.2014.2356. Epub 2014 Mar 21.